Unveiling the Biosimilar Paradox of Oncologists ’ Perceptions and Hesitations in South Korea: A Web-Based Survey Study

ConclusionKorean oncologists perceived biosimilars to be as safe and effective as originators. However, there is a notable mismatch between this perception and their prescribing practices, particularly among those who have not prescribed biosimilars before. The financial burden of patients served as a significant driver for prescribing biosimilars, yet marginal price differences between originators and biosimilars may be associated with the low adoption rate of biosimilars in Korea. Active price competition may enhance market penetration of biosimilars.
Source: BioDrugs - Category: Drugs & Pharmacology Source Type: research